U.S. health spending increased by 6.9% in 2005;
Slowest growth rate since 1999, but twice the rate
of inflation, CMS study finds
Jan 09, 2007--U.S. health care spending increased
6.9% in 2005, marking the third consecutive year
that the growth rate declined, according to an
annual government report published in the
January/February issue of
Health Affairs,
the
New York Times
reports.
The growth rate was the lowest reported since 1999
(Pear, New York Times, 1/9). The health
spending growth rate in 2004 was 7.2% (Alonso-Zaldivar,
Los Angeles Times,
1/9).
The report, prepared by the
CMS Office of
the Actuary, states, "This might be an encouraging
sign for the individuals, businesses and governments
that finance health care; however, it is unclear
whether this ... is temporary or indicative of a
long-term trend" (Appleby,
USA Today,
1/9).
According to the report, the U.S. spent $1.988
trillion, or $6,697 per person, on health care in
2005. State and federal governments paid about 40%
of health care costs, totaling $736.3 billion
(Zhang, Wall Street Journal, 1/9).
Though the rate of growth in health spending slowed,
it continued to rise more quickly than the economy
as a whole, wages, and general inflation (Los
Angeles Times, 1/9). Health spending accounted
for 16% of the gross domestic product in 2005, up
from 15.9% the previous year. Public-sector spending
on health care increased 7.8% in 2005, compared with
a 7% growth rate for businesses and a 6.2% increase
for households, according to the report (Zhang,
Wall Street Journal, 1/9).
Prescription Drug Costs
A slowdown in prescription drug spending growth was
the largest reason for the lower overall growth rate
during 2005, according to the report (Krasner,
Boston Globe,
1/9). Spending on prescription drugs increased 5.8%
in 2005, marking the first time since 1993 that drug
spending grew more slowly than overall health care
costs.
The drug spending growth rate has declined each year
since 1999, when it peaked at 18.2%. Drug spending
totaled $200.7 billion in 2005, representing 10
cents of every dollar spent on health care (New
York Times, 1/9).
Health insurers have slowed the growth of drug
spending with tiered plans that have patients pay
larger copayments for brand-name drugs than generic
drugs, the Globe reports. Separate insurance
efforts have encouraged the use of less expensive
drugs, with more expensive drugs being used only
when cheaper products are ineffective (Boston
Globe, 1/9).
Medicaid spending on prescription drugs increased
2.8% in 2005, coming after an average annual
increase of 15.4% from 1994 through 2004, according
to
HHS economist
Aaron Catlin, the principal author of the report.
Catlin said that 42 states had slower Medicaid drug
spending increases in 2005 than in 2004 by taking
such actions as pooling their buying power,
negotiating discounts with manufacturers and
increasing the use of generic drugs (New York
Times, 1/9).
Other contributing factors to the drug spending
slowdown were pharmaceutical companies' decelerated
introduction of new drugs, as well as the immediate
aftermath of the withdrawal of Vioxx from the market
because of safety concerns, the report found. The
report does not include data on the Medicare
prescription drug benefit, which was implemented in
2006 (Wall Street Journal, 1/9).
Additional Results
The report also contains the following findings:
-
Home health care was the fastest-growing
spending category in 2005, increasing 11% in
2005 -- the third consecutive year of
double-digit growth. Spending on home health
care totaled $47.5 billion.
-
Spending on hospital care increased 7.9% in
2005, while spending on physicians increased 7%
(New York Times, 1/9).
-
Health insurance premium rates increased 6.6% in
2005, "continuing a moderating trend seen in the
past couple of years," USA Today reports.
-
Out-of-pocket expenses for workers increased
5.8% in 2005, up from 5% in 2004 (USA Today,
1/9).
An
abstract of the study is available
online.
Reaction
Cathy Cowan, an economist who co-wrote the report,
said, "To have a slowdown for three straight years
is pretty significant." Cowan said a "convergence"
of the GDP growth rate and the health care spending
growth rate "means that health care costs are not
consuming more of the economy" (Boston Globe,
1/9).
Joseph Minarik, an economist and senior vice
president of the
Committee for Economic
Development, said, "I suspect that what
we're seeing is something like we observed in the
early 1990s, that as costs go up some resistance is
being thrown in their path. But the resistance is
not a fundamental change, and the fundamentals in
the system will continue to push costs higher" (Los
Angeles Times, 1/9).
Paul Ginsburg, president of the
Center for Studying
Health System Change, said the growing
economy might lead to larger health spending
increases in several years. Ginsburg said, "We have
a strong growth in jobs and sharp pay increases.
These are conditions that will lead to a cyclically
higher rate of spending, say in '08 or '09" (USA
Today, 1/9).
Henry Simmons, president of the
National Coalition on
Health Care, said, "It would be a
disaster if people thought these (spending) numbers
mean the crisis is over. Even if costs are only
going up at 6.9%, that is still two or three times
the rate of growth in take-home pay. It is still
unsustainable" (Los Angeles Times, 1/9).
A
webcast of a panel discussion analyzing the study's
findings -- including several members of the CMS
National Health Statistics Group and a senior
economist at the Agency for Healthcare Research and
Quality -- is available
online at
kaisernetwork.org.